First-line toripalimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma: A cost-effectiveness analysis.
Saved in:
| Title: | First-line toripalimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma: A cost-effectiveness analysis. |
|---|---|
| Authors: | Han, Jing-Wen1,2 (AUTHOR), Zhong, Yu3 (AUTHOR), Zhong, Jin4 (AUTHOR), Zeng, Wen-Jing5 (AUTHOR) 29761320@qq.com, Sun, Li-Jun6,7,8 (AUTHOR) zengwenjing89@csu.edu.cn |
| Source: | PLoS ONE. 6/10/2025, Vol. 20 Issue 6, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0325808 |
